UniProt ID | NUCB1_HUMAN | |
---|---|---|
UniProt AC | Q02818 | |
Protein Name | Nucleobindin-1 | |
Gene Name | NUCB1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 461 | |
Subcellular Localization |
Golgi apparatus, cis-Golgi network membrane Peripheral membrane protein Lumenal side . Cytoplasm . Secreted . A small fraction of the protein may be cytoplasmic. |
|
Protein Description | Major calcium-binding protein of the Golgi. May have a role in calcium homeostasis (By similarity).. | |
Protein Sequence | MPPSGPRGTLLLLPLLLLLLLRAVLAVPLERGAPNKEETPATESPDTGLYYHRYLQEVIDVLETDGHFREKLQAANAEDIKSGKLSRELDFVSHHVRTKLDELKRQEVSRLRMLLKAKMDAEQDPNVQVDHLNLLKQFEHLDPQNQHTFEARDLELLIQTATRDLAQYDAAHHEEFKRYEMLKEHERRRYLESLGEEQRKEAERKLEEQQRRHREHPKVNVPGSQAQLKEVWEELDGLDPNRFNPKTFFILHDINSDGVLDEQELEALFTKELEKVYDPKNEEDDMREMEEERLRMREHVMKNVDTNQDRLVTLEEFLASTQRKEFGDTGEGWETVEMHPAYTEEELRRFEEELAAREAELNAKAQRLSQETEALGRSQGRLEAQKRELQQAVLHMEQRKQQQQQQQGHKAPAAHPEGQLKFHPDTDDVPVPAPAGDQKEVDTSEKKLLERLPEVEVPQHL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
4 | Phosphorylation | ----MPPSGPRGTLL ----CCCCCHHHHHH | 56.40 | 20068231 | |
39 | O-linked_Glycosylation | GAPNKEETPATESPD CCCCCCCCCCCCCCC | 21.22 | 30059200 | |
39 | Phosphorylation | GAPNKEETPATESPD CCCCCCCCCCCCCCC | 21.22 | 23898821 | |
42 | O-linked_Glycosylation | NKEETPATESPDTGL CCCCCCCCCCCCCCH | 37.89 | 30059200 | |
42 | Phosphorylation | NKEETPATESPDTGL CCCCCCCCCCCCCCH | 37.89 | 23898821 | |
44 | Phosphorylation | EETPATESPDTGLYY CCCCCCCCCCCCHHH | 24.58 | 23898821 | |
44 | O-linked_Glycosylation | EETPATESPDTGLYY CCCCCCCCCCCCHHH | 24.58 | 30059200 | |
47 | Phosphorylation | PATESPDTGLYYHRY CCCCCCCCCHHHHHH | 32.25 | 23898821 | |
47 | O-linked_Glycosylation | PATESPDTGLYYHRY CCCCCCCCCHHHHHH | 32.25 | 30059200 | |
50 | O-linked_Glycosylation | ESPDTGLYYHRYLQE CCCCCCHHHHHHHHH | 9.89 | 55826313 | |
50 | Phosphorylation | ESPDTGLYYHRYLQE CCCCCCHHHHHHHHH | 9.89 | 23898821 | |
51 | Phosphorylation | SPDTGLYYHRYLQEV CCCCCHHHHHHHHHH | 5.71 | 23898821 | |
64 | Phosphorylation | EVIDVLETDGHFREK HHHHHHHCCCHHHHH | 43.02 | - | |
71 | 2-Hydroxyisobutyrylation | TDGHFREKLQAANAE CCCHHHHHHHHCCHH | 41.46 | - | |
81 | 2-Hydroxyisobutyrylation | AANAEDIKSGKLSRE HCCHHHHHCCCCHHH | 66.53 | - | |
81 | Ubiquitination | AANAEDIKSGKLSRE HCCHHHHHCCCCHHH | 66.53 | - | |
82 | Phosphorylation | ANAEDIKSGKLSREL CCHHHHHCCCCHHHH | 41.30 | 23927012 | |
86 | Phosphorylation | DIKSGKLSRELDFVS HHHCCCCHHHHHHHH | 27.48 | 23927012 | |
93 | O-linked_Glycosylation | SRELDFVSHHVRTKL HHHHHHHHHHHHHHH | 14.10 | 20068231 | |
93 | Phosphorylation | SRELDFVSHHVRTKL HHHHHHHHHHHHHHH | 14.10 | 20068231 | |
104 | 2-Hydroxyisobutyrylation | RTKLDELKRQEVSRL HHHHHHHHHHHHHHH | 50.41 | - | |
119 | Sulfoxidation | RMLLKAKMDAEQDPN HHHHHHHCCCCCCCC | 7.63 | 30846556 | |
148 | Phosphorylation | LDPQNQHTFEARDLE CCCCCCCCCHHHHHH | 17.26 | 28355574 | |
148 | O-linked_Glycosylation | LDPQNQHTFEARDLE CCCCCCCCCHHHHHH | 17.26 | 54914103 | |
160 | O-linked_Glycosylation | DLELLIQTATRDLAQ HHHHHHHHHHHHHHH | 24.01 | 55824735 | |
162 | O-linked_Glycosylation | ELLIQTATRDLAQYD HHHHHHHHHHHHHHH | 28.27 | 55824741 | |
168 | O-linked_Glycosylation | ATRDLAQYDAAHHEE HHHHHHHHHHHCHHH | 11.27 | 70957953 | |
168 | Phosphorylation | ATRDLAQYDAAHHEE HHHHHHHHHHHCHHH | 11.27 | - | |
177 | Acetylation | AAHHEEFKRYEMLKE HHCHHHHHHHHHHHH | 58.30 | 25825284 | |
179 | Phosphorylation | HHEEFKRYEMLKEHE CHHHHHHHHHHHHHH | 13.28 | 22817900 | |
183 | 2-Hydroxyisobutyrylation | FKRYEMLKEHERRRY HHHHHHHHHHHHHHH | 56.57 | - | |
190 | Phosphorylation | KEHERRRYLESLGEE HHHHHHHHHHHHCHH | 17.01 | 28152594 | |
224 | O-linked_Glycosylation | PKVNVPGSQAQLKEV CCCCCCCCHHHHHHH | 19.10 | 17525332 | |
224 | Phosphorylation | PKVNVPGSQAQLKEV CCCCCCCCHHHHHHH | 19.10 | 17525332 | |
229 | Ubiquitination | PGSQAQLKEVWEELD CCCHHHHHHHHHHHC | 37.83 | - | |
277 | Phosphorylation | TKELEKVYDPKNEED HHHHHHHHCCCCCHH | 37.28 | - | |
302 | Ubiquitination | RMREHVMKNVDTNQD HHHHHHHHHCCCCHH | 53.37 | - | |
310 | Methylation | NVDTNQDRLVTLEEF HCCCCHHHHHHHHHH | 22.69 | 115485705 | |
313 | O-linked_Glycosylation | TNQDRLVTLEEFLAS CCHHHHHHHHHHHHH | 32.80 | 55832629 | |
320 | O-linked_Glycosylation | TLEEFLASTQRKEFG HHHHHHHHHCHHHHC | 27.50 | 55832635 | |
320 | Phosphorylation | TLEEFLASTQRKEFG HHHHHHHHHCHHHHC | 27.50 | 28348404 | |
321 | Phosphorylation | LEEFLASTQRKEFGD HHHHHHHHCHHHHCC | 27.13 | 28348404 | |
321 | O-linked_Glycosylation | LEEFLASTQRKEFGD HHHHHHHHCHHHHCC | 27.13 | 55832641 | |
335 | Phosphorylation | DTGEGWETVEMHPAY CCCCCCEEEECCCCC | 18.43 | 29507054 | |
338 | Sulfoxidation | EGWETVEMHPAYTEE CCCEEEECCCCCCHH | 3.89 | 30846556 | |
343 | Phosphorylation | VEMHPAYTEEELRRF EECCCCCCHHHHHHH | 38.74 | - | |
369 | Phosphorylation | NAKAQRLSQETEALG HHHHHHHHHHHHHHH | 28.32 | 29255136 | |
369 | O-linked_Glycosylation | NAKAQRLSQETEALG HHHHHHHHHHHHHHH | 28.32 | 17525332 | |
372 | Phosphorylation | AQRLSQETEALGRSQ HHHHHHHHHHHHHHH | 20.94 | 23927012 | |
372 | O-linked_Glycosylation | AQRLSQETEALGRSQ HHHHHHHHHHHHHHH | 20.94 | 29134961 | |
378 | O-linked_Glycosylation | ETEALGRSQGRLEAQ HHHHHHHHHHHHHHH | 34.88 | 55828285 | |
378 | Phosphorylation | ETEALGRSQGRLEAQ HHHHHHHHHHHHHHH | 34.88 | - | |
396 | Sulfoxidation | LQQAVLHMEQRKQQQ HHHHHHHHHHHHHHH | 4.03 | 30846556 | |
426 | O-linked_Glycosylation | QLKFHPDTDDVPVPA CCCCCCCCCCCCCCC | 38.25 | 55832931 | |
443 | Phosphorylation | GDQKEVDTSEKKLLE CCCCCCCHHHHHHHH | 43.92 | 26699800 | |
444 | O-linked_Glycosylation | DQKEVDTSEKKLLER CCCCCCHHHHHHHHH | 42.85 | 55834541 | |
444 | Phosphorylation | DQKEVDTSEKKLLER CCCCCCHHHHHHHHH | 42.85 | 26699800 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of NUCB1_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of NUCB1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RBL1_HUMAN | RBL1 | physical | 21988832 | |
SET_HUMAN | SET | physical | 21988832 | |
XPO1_HUMAN | XPO1 | physical | 21988832 | |
PGH2_HUMAN | PTGS2 | physical | 18493301 | |
CBS_HUMAN | CBS | physical | 22863883 | |
PYRG2_HUMAN | CTPS2 | physical | 22863883 | |
GTF2I_HUMAN | GTF2I | physical | 22863883 | |
PRKDC_HUMAN | PRKDC | physical | 22863883 | |
RD23B_HUMAN | RAD23B | physical | 22863883 | |
SYWC_HUMAN | WARS | physical | 22863883 | |
REL_HUMAN | REL | physical | 25416956 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-224 AND SER-369, ANDMASS SPECTROMETRY. | |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-179, AND MASSSPECTROMETRY. |